138 related articles for article (PubMed ID: 38642508)
21. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.
Dima A; Jurcut C; Baicus C
Rheumatol Int; 2018 Jul; 38(7):1169-1178. PubMed ID: 29796907
[TBL] [Abstract][Full Text] [Related]
22. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
23. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
Gunnarsson R; El-Hage F; Aaløkken TM; Reiseter S; Lund MB; Garen T; ; Molberg Ø
Rheumatology (Oxford); 2016 Jan; 55(1):103-8. PubMed ID: 26320136
[TBL] [Abstract][Full Text] [Related]
24. Immunological analysis of pulmonary hypertension in connective tissue diseases.
Nishimaki T; Aotsuka S; Kondo H; Yamamoto K; Takasaki Y; Sumiya M; Yokohari R
J Rheumatol; 1999 Nov; 26(11):2357-62. PubMed ID: 10555891
[TBL] [Abstract][Full Text] [Related]
25. Clinical and serological hallmarks of systemic sclerosis overlap syndromes.
Pakozdi A; Nihtyanova S; Moinzadeh P; Ong VH; Black CM; Denton CP
J Rheumatol; 2011 Nov; 38(11):2406-9. PubMed ID: 21844148
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
27. Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease.
Takeshita M; Suzuki K; Nakazawa M; Kamata H; Ishii M; Oyamada Y; Oshima H; Takeuchi T
J Autoimmun; 2021 Jul; 121():102661. PubMed ID: 34034155
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy outcomes in mixed connective tissue disease: a multicentre study.
Radin M; Schreiber K; Cuadrado MJ; Cecchi I; Andreoli L; Franceschini F; Caleiro T; Andrade D; Gibbone E; Khamashta M; Buyon J; Izmirly P; Aguirre MA; Benedetto C; Roccatello D; Marozio L; Sciascia S
Rheumatology (Oxford); 2019 Nov; 58(11):2000-2008. PubMed ID: 31079145
[TBL] [Abstract][Full Text] [Related]
29. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
[TBL] [Abstract][Full Text] [Related]
30. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
[TBL] [Abstract][Full Text] [Related]
31. Negative correlation of anti-U1RNP antibody titers and the amount of salivary secretion with age correction.
Takada K; Suzuki K; Matsumoto M; Okada M; Nakanishi T; Horikoshi H; Higuchi T; Ohsuzu F
Intern Med; 2008; 47(5):385-90. PubMed ID: 18310968
[TBL] [Abstract][Full Text] [Related]
32. Nailfold capillaroscopy changes associated with anti-RNP antibodies in systemic lupus erythematosus.
Chebbi PP; Goel R; Ramya J; Gowri M; Herrick A; Danda D
Rheumatol Int; 2022 Aug; 42(8):1355-1361. PubMed ID: 34076720
[TBL] [Abstract][Full Text] [Related]
33. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
[TBL] [Abstract][Full Text] [Related]
34. [Mixed connective tissue disease--etiology, pathogenesis, clinical significance, treatment].
Zdrojewicz Z; Budzyń-Kozioł E; Puławska J
Postepy Hig Med Dosw; 1999; 53(5):751-66. PubMed ID: 10645148
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein.
Okawa-Takatsuji M; Aotsuka S; Fujinami M; Uwatoko S; Kinoshita M; Sumiya M
Clin Exp Immunol; 1999 Apr; 116(1):174-80. PubMed ID: 10209523
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies.
van den Hoogen FH; Spronk PE; Boerbooms AM; Bootsma H; de Rooij DJ; Kallenberg CG; van de Putte LB
Br J Rheumatol; 1994 Dec; 33(12):1117-20. PubMed ID: 8000737
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis.
Martel ME; Leurs A; Launay D; Behal H; Chepy A; Collet A; Sanges S; Hachulla E; Dubucquoi S; Dauchet L; Sobanski V
Autoimmun Rev; 2024 May; 23(5):103536. PubMed ID: 38555075
[TBL] [Abstract][Full Text] [Related]
38. The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Kubo M; Tamaki K
J Invest Dermatol; 2003 Feb; 120(2):204-10. PubMed ID: 12542523
[TBL] [Abstract][Full Text] [Related]
39. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.
Vegh J; Szodoray P; Kappelmayer J; Csipo I; Udvardy M; Lakos G; Aleksza M; Soltesz P; Szilágyi A; Zeher M; Szegedi G; Bodolay E
Scand J Immunol; 2006 Jul; 64(1):69-76. PubMed ID: 16784493
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
